DSPE-PEG-Anti-HER2 Fab䣨Ӳ֬֬Ҵ-Ҷ-)
l(f)r(sh)g2022-03-30 ֬-Ҷ-Anti-HER2 Fab PEG:2000;3000;5000 DSPE-PEG-Anti-HER2 Fab
؛̖(ho) | Ҏ(gu) | (sh) | r(ji) |
---|---|---|---|
Q-0056835 | 100mg |
1
|
ԃr(ji) |
Q-0056835 | 250mg |
1
|
ԃr(ji) |
Q-0056835 | 500mg |
1
|
ԃr(ji) |
Q-0056835 | 1g |
1
|
ԃr(ji) |
Q-0056835 | 5g |
1
|
ԃr(ji) |
ӆُ(gu)/bԃ
N۽(jng)

I(y)(w)ЙC(j) | Ӳ | ٴ | | {a(chn)Ʒ
ԓa(chn)Ʒa(chn)ۺ}Ո(qng)(lin)ϵ҂
a(chn)ƷB
DSPE-PEG-Anti-HER2 Fab′
Ӳ֬֬Ҵ-Ҷ-
֬-Ҷ-Anti-HER2 Fab′
PEG:2000;3000;5000 DSPE-PEG-Anti-HER2 Fab′
P(gun)a(chn)Ʒ
DSPE-PEG-Anti-HER2 Fab′Ӳ֬֬Ҵ-Ҷ-) | pgӹٷ |
DSPE-PEG-αCD19Ӳ֬֬Ҵ-Ҷ-) | pgӹٷ |
DSPE-PEG-αCD20mAbӲ֬֬Ҵ-Ҷ-) | pgӹٷ |
DSPE-PEG-Anti-rat CC531mAbӲ֬֬Ҵ-Ҷ-) | pgӹٷ |
DSPE-PEG-F(ab’)2of GAHӲ֬֬Ҵ-Ҷ-) | pgӹٷ |
DSPE-PEG-anti-EGFR scFv C10Ӳ֬֬Ҵ-Ҷ-) | pgӹٷ |
Ӳ֬֬Ҵ-Ҷ-)DSPE-PEG-Fab’of C225 mAb(cetuximab) | pgӹٷ |
DSPE-PEG-Fab’of matuzumab or C225Ӳ֬֬Ҵ-Ҷ-) | pgӹٷ |
DSPE-PEG-mAb 2C5Ӳ֬֬Ҵ-Ҷ-) | pgӹٷ |
a(chn)أ
ȣ99%
;Hڿ
YρС2022.03.29
(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|(zh)ָ(bio) | 95%+ |
ܽl | ЙC(j)܄/ˮ |
CAS̖(ho) | N/A |
N/A | |
(ch)l | -20ܹⱣ |
(ch)r(sh)g | 1 |
\(yn)ݔl | Ҝ2 |
a(chn)Sң | pgӹٷƼ˾ |
P(gun)a(chn)Ʒ
-
DSPE-PEG-FA һN͵İ֬-ҶPEGPEGĩ~ᣨFolic Acid, FAԓϽY(ji)DSPE֬PEGL(zhng)HˮԾۺFAСӰwă(yu)c(din)߂õHˮԺ[
-
ӢCy5-PEG-NH? s2000 Da CY5-PEG2K-NH2Cy5(bio)ӛPEGľҶA(ch)һ˘(bio)ӛCy5ɹȾһ˱CNH?܈F(tun)Cy5һNtɹȾl(f)䲨L(zhng)s670 nmеͱ(qing)̖(ho)ⷀ(wn)c(din)
-
l(f)r(sh)g2022-03-30 ֬-Ҷ-צCD19 PEG:2000;3000;5000 DSPE-PEG-CD19
-
l(f)r(sh)g2022-03-30 ֬-Ҷ-צCD20mAb PEG:2000;3000;5000 DSPE-PEG-CD20mAb